Stem Cell Transplantation

Oncosis reveals efficacy of disease-free stem cell transplant technology

Published in Blood Weekly, April 18th, 2002

"Delivery of a disease-free, autologous hematopoietic stem cell (HSC) transplant for cancer patients has been a goal of the cancer research community for many years," Manfred Koller, PhD, vice president, R&D and chief operating officer of Oncosis, told the 2002 Tandem Bone Marrow Transplant (BMT) conference in Orlando, Florida.

"Patented photosis technology being developed by Oncosis delivers a substantially improved purging procedure, eliminating tumor cells and resulting in a disease-free product. Using photosis in recent laboratory trials, we have established the degree of tumor contamination down to the level of one detectable cell in an entire transplant. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-04-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry